Donate
This isn't hypothetical research.
It's happening right now.
Your gift funds the CHARIOT study at Memorial Sloan Kettering, led by Dr. Dana E. Rathkopf — a clinical trial combining treatments that lower testosterone and block prostate cancer's ability to grow, aiming to stop high-risk cancer before surgery and reduce the chance of it returning.
$85,000
raised, in Tom's memory
More emotional & powerful
Tom Churylo believed that with enough curiosity, determination, and hard work, almost anything could be improved. That belief didn't stop when he was diagnosed with metastatic prostate cancer in 2020 — it's what led him to enroll in a Phase I clinical trial at Memorial Sloan Kettering Cancer Center.
He knew the trial might not save him. He did it anyway, because of what researchers could learn from him — and who that knowledge might help next.
"Maybe they'll learn a lot more from me than someone less healthy."
That belief is still at work today. Dr. Dana E. Rathkopf — the physician Tom trusted — is currently leading the CHARIOT study at Memorial Sloan Kettering. The trial targets high-risk prostate cancer by combining treatments that lower testosterone and block the cancer's ability to grow — with the goal of stopping cancer before surgery and reducing the chance of it returning. This is the same kind of research Tom believed in, happening right now.
We never thought it would be us. Now we run — and give — so other families have more time.
Your donation today funds real, active research. Not someday. Now.